Overview: CMV Quantitative PCR TestIntroduction: The CMV Quantitative PCR Test measures cytomegalovirus DNA to monitor infection in immunocompromised patients, causing fever or organ issues. Aligned with 2023 IDSA guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding antiviral therapy, monitoring treatment response, and improving outcomes in virology for patients with suspected CMV infections.
Other Names: CMV Quant PCR Assay, Cytomegalovirus DNA Quantification Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: CMV PCR testing began in the 1990s with molecular diagnostics. Quantitative PCR emerged in the 2000s, improving monitoring accuracy for viral load.
Purpose: Quantifies CMV viral load, guides antiviral therapy, and monitors infection in patients with fever or organ issues.
Test Parameters: 1. Cytomegalovirus DNA
Pretest Condition: No fasting required. Collect whole blood, serum, plasma, CSF, urine, amniotic fluid, or saliva at any time. Report symptoms like fever or organ dysfunction, and list immunocompromising conditions.
Specimen: 2-5 mL whole blood (EDTA), 2-5 mL serum (SST), 2-4 mL plasma (EDTA), 1-2 mL CSF (sterile container), 5-20 mL urine (sterile container), 1-2 mL amniotic fluid (sterile container), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, organ dysfunction, or immunocompromised states (e.g., HIV, transplant). Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiviral therapy.
Procedural Considerations: Uses quantitative PCR to measure CMV DNA levels. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Low viral load or improper storage can cause false negatives. Contamination may cause false positives.
Clinical Significance: High viral load confirms active CMV infection, prompting antiviral therapy. Low or undetectable levels indicate treatment response or inactive infection.
Specialist Consultation: Consult an infectious disease specialist or transplant specialist for result interpretation.
Additional Supporting Tests: CMV IgG/IgM, viral culture, or organ imaging to confirm infection or assess complications.
Test Limitations: False negatives may occur with low viral load. Results require clinical correlation.
References: IDSA CMV Guidelines, 2023; Clinical Infectious Diseases, Ljungman P, 2022.
